First Trust Nasdaq Pharmaceuticals ETF (FTXH)

NASDAQ: FTXH · IEX Real-Time Price · USD
25.81
-0.17 (-0.64%)
Sep 22, 2023, 4:00 PM EDT - Market closed
-0.64%
Assets $22.88M
Expense Ratio 0.60%
PE Ratio 15.39
Shares Out n/a
Dividend (ttm) $0.42
Dividend Yield 1.61%
Ex-Dividend Date Sep 22, 2023
Payout Ratio 24.79%
1-Year Return +4.97%
Volume 660
Open 26.04
Previous Close 25.98
Day's Range 25.81 - 26.04
52-Week Low 23.87
52-Week High 28.59
Beta n/a
Holdings 51
Inception Date Sep 20, 2016

About FTXH

Fund Home Page

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is issued by First Trust.

Asset Class Equity
Category Health
Region North America
Stock Exchange NASDAQ
Ticker Symbol FTXH
Index Tracked Nasdaq US Smart Pharmaceuticals Index

Top 10 Holdings

55.06% of assets
Name Symbol Weight
AbbVie Inc. ABBV 7.72%
Johnson & Johnson JNJ 7.39%
Merck & Co., Inc. MRK 7.24%
Bristol-Myers Squibb Company BMY 7.08%
Pfizer Inc. PFE 6.86%
Amgen Inc. AMGN 3.88%
Cardinal Health, Inc. CAH 3.77%
Vertex Pharmaceuticals Incorporated VRTX 3.76%
Regeneron Pharmaceuticals, Inc. REGN 3.68%
Eli Lilly and Company LLY 3.67%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
2023-09-22 $0.0725 2023-09-29
2023-06-27 $0.1179 2023-06-30
2023-03-24 $0.1001 2023-03-31
2022-12-23 $0.1253 2022-12-30
2022-09-23 $0.0911 2022-09-30
2022-06-24 $0.0384 2022-06-30
Full Dividend History

News

ETF Spotlight: Pharmaceuticals driven higher by Pfizer

CNBC'S Morgan Brennan takes a look at pharmaceutical as Pfizer's positive vaccine news has led the sector higher.

3 years ago - CNBC Television